Literature DB >> 23984834

Conservation of apolipoprotein A-I's central domain structural elements upon lipid association on different high-density lipoprotein subclasses.

Michael N Oda1, Madhu S Budamagunta, Ethan G Geier, Sajiv H Chandradas, Baohai Shao, Jay W Heinecke, John C Voss, Giorgio Cavigiolio.   

Abstract

The antiatherogenic properties of apolipoprotein A-I (apoA-I) are derived, in part, from lipidation-state-dependent structural elements that manifest at different stages of apoA-I's progression from lipid-free protein to spherical high-density lipoprotein (HDL). Previously, we reported the structure of apoA-I's N-terminus on reconstituted HDLs (rHDLs) of different sizes. We have now investigated at the single-residue level the conformational adaptations of three regions in the central domain of apoA-I (residues 119-124, 139-144, and 164-170) upon apoA-I lipid binding and HDL formation. An important function associated with these residues of apoA-I is the activation of lecithin:cholesterol acyltransferase (LCAT), the enzyme responsible for catalyzing HDL maturation. Structural examination was performed by site-directed tryptophan fluorescence and spin-label electron paramagnetic resonance spectroscopies for both the lipid-free protein and rHDL particles 7.8, 8.4, and 9.6 nm in diameter. The two methods provide complementary information about residue side chain mobility and molecular accessibility, as well as the polarity of the local environment at the targeted positions. The modulation of these biophysical parameters yielded new insight into the importance of structural elements in the central domain of apoA-I. In particular, we determined that the loosely lipid-associated structure of residues 134-145 is conserved in all rHDL particles. Truncation of this region completely abolished LCAT activation but did not significantly affect rHDL size, reaffirming the important role of this structural element in HDL function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23984834      PMCID: PMC3835726          DOI: 10.1021/bi4007012

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  86 in total

1.  The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction.

Authors:  Zhiping Wu; Matthew A Wagner; Lemin Zheng; John S Parks; Jacinto M Shy; Jonathan D Smith; Valentin Gogonea; Stanley L Hazen
Journal:  Nat Struct Mol Biol       Date:  2007-08-05       Impact factor: 15.369

2.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Authors:  Tomas Vaisar; Subramaniam Pennathur; Pattie S Green; Sina A Gharib; Andrew N Hoofnagle; Marian C Cheung; Jaeman Byun; Simona Vuletic; Sean Kassim; Pragya Singh; Helen Chea; Robert H Knopp; John Brunzell; Randolph Geary; Alan Chait; Xue-Qiao Zhao; Keith Elkon; Santica Marcovina; Paul Ridker; John F Oram; Jay W Heinecke
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

3.  Methods and applications of site-directed spin labeling EPR spectroscopy.

Authors:  Candice S Klug; Jimmy B Feix
Journal:  Methods Cell Biol       Date:  2008       Impact factor: 1.441

4.  Molecular models need to be tested: the case of a solar flares discoidal HDL model.

Authors:  Amy Y Shih; Stephen G Sligar; Klaus Schulten
Journal:  Biophys J       Date:  2008-03-28       Impact factor: 4.033

Review 5.  Antiatherogenic functionality of high density lipoprotein: how much versus how good.

Authors:  Dmitri Sviridov; Nigora Mukhamedova; Alan T Remaley; Jaye Chin-Dusting; Paul Nestel
Journal:  J Atheroscler Thromb       Date:  2008-04-03       Impact factor: 4.928

6.  The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses.

Authors:  Giorgio Cavigiolio; Baohai Shao; Ethan G Geier; Gang Ren; Jay W Heinecke; Michael N Oda
Journal:  Biochemistry       Date:  2008-03-27       Impact factor: 3.162

Review 7.  Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins.

Authors:  A R Tall
Journal:  J Intern Med       Date:  2008-03       Impact factor: 8.989

8.  Conformational adaptation of apolipoprotein A-I to discretely sized phospholipid complexes.

Authors:  Shaila Bhat; Mary G Sorci-Thomas; Rubina Tuladhar; Michael P Samuel; Michael J Thomas
Journal:  Biochemistry       Date:  2007-06-12       Impact factor: 3.162

9.  Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I.

Authors:  Baohai Shao; Giorgio Cavigiolio; Nathan Brot; Michael N Oda; Jay W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

10.  Characterization and properties of pre beta-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I.

Authors:  Phu T Duong; Ginny L Weibel; Sissel Lund-Katz; George H Rothblat; Michael C Phillips
Journal:  J Lipid Res       Date:  2008-02-05       Impact factor: 5.922

View more
  2 in total

1.  Spectroscopic Characterization of Structural Changes in Membrane Scaffold Proteins Entrapped within Mesoporous Silica Gel Monoliths.

Authors:  Wade F Zeno; Silvia Hilt; Subhash H Risbud; John C Voss; Marjorie L Longo
Journal:  ACS Appl Mater Interfaces       Date:  2015-04-20       Impact factor: 9.229

2.  Proteolysis of apolipoprotein A-I by secretory phospholipase A₂: a new link between inflammation and atherosclerosis.

Authors:  Giorgio Cavigiolio; Shobini Jayaraman
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.